236 related articles for article (PubMed ID: 28945273)
41. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.
Delgado M; Robledo G; Rueda B; Varela N; O'Valle F; Hernandez-Cortes P; Caro M; Orozco G; Gonzalez-Rey E; Martin J
Arthritis Rheum; 2008 Apr; 58(4):1010-9. PubMed ID: 18383379
[TBL] [Abstract][Full Text] [Related]
42. Vasoactive intestinal peptide inhibits toll-like receptor 3-induced nitric oxide production in Schwann cells and subsequent sensory neuronal cell death in vitro.
Lee H; Park K; Kim JS; Lee SJ
J Neurosci Res; 2009 Jan; 87(1):171-8. PubMed ID: 18683246
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of vasoactive intestinal peptide receptors and cyclooxygenase-2 in human prostate cancer. Analysis of potential prognostic relevance.
Fernández-Martínez AB; Carmena MJ; Arenas MI; Bajo AM; Prieto JC; Sánchez-Chapado M
Histol Histopathol; 2012 Aug; 27(8):1093-101. PubMed ID: 22763881
[TBL] [Abstract][Full Text] [Related]
44. VPAC1 receptor expression in peripheral blood mononuclear cells in a human endotoxemia model.
Storka A; Burian B; Führlinger G; Clive B; Sun T; Crevenna R; Gsur A; Mosgöller W; Wolzt M
J Transl Med; 2013 May; 11():117. PubMed ID: 23651810
[TBL] [Abstract][Full Text] [Related]
45. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I
J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170
[TBL] [Abstract][Full Text] [Related]
46. VIP Modulation of Hippocampal Synaptic Plasticity: A Role for VIP Receptors as Therapeutic Targets in Cognitive Decline and Mesial Temporal Lobe Epilepsy.
Cunha-Reis D; Caulino-Rocha A
Front Cell Neurosci; 2020; 14():153. PubMed ID: 32595454
[TBL] [Abstract][Full Text] [Related]
47. VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins.
Couvineau A; Laburthe M
Br J Pharmacol; 2012 May; 166(1):42-50. PubMed ID: 21951273
[TBL] [Abstract][Full Text] [Related]
48. Gene expression of vasoactive intestinal peptide receptors in human lung cancer.
Szilasi M; Buglyo A; Treszl A; Kiss L; Schally AV; Halmos G
Int J Oncol; 2011 Oct; 39(4):1019-24. PubMed ID: 21769421
[TBL] [Abstract][Full Text] [Related]
49. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
Nachtergael I; Gaspard N; Langlet C; Robberecht P; Langer I
Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
[TBL] [Abstract][Full Text] [Related]
50. A subnanomolar concentration of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) pre-synaptically modulates glutamatergic transmission in the rat hippocampus acting through acetylcholine.
Pecoraro V; Sardone LM; Chisari M; Licata F; Li Volsi G; Perciavalle V; Ciranna L; Costa L
Neuroscience; 2017 Jan; 340():551-562. PubMed ID: 27816700
[TBL] [Abstract][Full Text] [Related]
51. GABAB receptor transduction mechanisms, and cross-talk between protein kinases A and C, in GABAergic terminals synapsing onto neurons of the rat nucleus basalis of Meynert.
Kubota H; Katsurabayashi S; Moorhouse AJ; Murakami N; Koga H; Akaike N
J Physiol; 2003 Aug; 551(Pt 1):263-76. PubMed ID: 12815184
[TBL] [Abstract][Full Text] [Related]
52. Activation of the VIP/VPAC2 system induces reactive astrocytosis associated with increased expression of glutamate transporters.
Nishimoto M; Miyakawa H; Wada K; Furuta A
Brain Res; 2011 Apr; 1383():43-53. PubMed ID: 21281617
[TBL] [Abstract][Full Text] [Related]
53. Opposing reduced VPAC
Serpa A; Bento M; Caulino-Rocha A; Pawlak S; Cunha-Reis D
Neurochem Int; 2022 Sep; 158():105383. PubMed ID: 35787395
[TBL] [Abstract][Full Text] [Related]
54. Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition.
Lopes LV; Cunha RA; Kull B; Fredholm BB; Ribeiro JA
Neuroscience; 2002; 112(2):319-29. PubMed ID: 12044450
[TBL] [Abstract][Full Text] [Related]
55. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
Schulz S; Röcken C; Mawrin C; Weise W; Höllt V; Schulz S
Clin Cancer Res; 2004 Dec; 10(24):8235-42. PubMed ID: 15623599
[TBL] [Abstract][Full Text] [Related]
56. VPAC1 and VPAC2 receptor deficiencies negatively influence pregnancy outcome through distinct and overlapping modulations of immune, trophoblast and vascular functions.
Calo G; Hauk V; Vota D; Van C; Condro M; Gallino L; Ramhorst R; Waschek J; Pérez Leirós C
Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166593. PubMed ID: 36328148
[TBL] [Abstract][Full Text] [Related]
57. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain.
Joo KM; Chung YH; Kim MK; Nam RH; Lee BL; Lee KH; Cha CI
J Comp Neurol; 2004 Aug; 476(4):388-413. PubMed ID: 15282712
[TBL] [Abstract][Full Text] [Related]
58. Vasoactive intestinal peptide increases VEGF expression to promote proliferation of brain vascular endothelial cells via the cAMP/PKA pathway after ischemic insult in vitro.
Yang J; Shi QD; Song TB; Feng GF; Zang WJ; Zong CH; Chang L
Peptides; 2013 Apr; 42():105-11. PubMed ID: 23340020
[TBL] [Abstract][Full Text] [Related]
59. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
[TBL] [Abstract][Full Text] [Related]
60. Vasoactive intestinal polypeptide VPAC1 and VPAC2 receptor chimeras identify domains responsible for the specificity of ligand binding and activation.
Juarranz MG; Van Rampelbergh J; Gourlet P; De Neef P; Cnudde J; Robberecht P; Waelbroeck M
Eur J Biochem; 1999 Oct; 265(1):449-56. PubMed ID: 10491203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
